JACKEDFORUMS

GHK-Cu

Glycyl-L-histidyl-L-lysine copper(II) complex · Copper tripeptide-1 · Copper peptide · Cu-GHK · Prezatide copper acetate

Copper-carrying tripeptide studied for collagen synthesis, wound repair and skin remodelling.

Typical dose

2 mg

1x daily

Range

1–3

mg

Half-life

see Dosing

Evidence

Early human

Topical · Subcutaneous

What it is

GHK is a naturally occurring human tripeptide that binds copper(II) with high affinity. Plasma levels are around 200 ng/mL in your twenties and fall to roughly 80 ng/mL — about 40% of the peak — by age sixty, which is the origin of most of the anti-ageing framing around it. The copper-bound form, GHK-Cu, is the biologically active species and is what gets sold.

Most of the evidence base is topical and cosmetic: controlled studies of copper-peptide creams on facial skin, hair follicles and wound beds, showing increased collagen and glycosaminoglycan synthesis and improved wound closure. Those trials are generally small and often industry-run, but they are real human data on real endpoints.

Injectable GHK-Cu is a different proposition. There is no human trial data for subcutaneous use at all, and unlike a peptide such as BPC-157 the compound carries an actual heavy metal into you. Copper is essential in microgram quantities and toxic in excess, and injecting it bypasses the gut's tight absorption control. This is the one peptide in the repair category where dose ceilings and cycle length are a genuine toxicology issue rather than a precaution.

How it works

GHK-Cu acts largely as a copper delivery vehicle and a gene-expression modulator. It shuttles copper to enzymes that need it — lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase, which handles oxidative stress — and it modulates the balance between matrix metalloproteinases and their tissue inhibitors, so it drives both the breakdown of damaged matrix and the deposition of new collagen, decorin and glycosaminoglycans.

Gene-expression profiling has shown GHK shifting expression of a very large number of genes, broadly in the direction of tissue remodelling and away from inflammatory and fibrotic programmes. That breadth is why the literature makes claims across skin, hair, wound and nerve tissue, and also why the mechanism is better described as pleiotropic than as targeted.

Dosing

Typical single dose2 mg
Reported range1–3 mg
Frequency1x daily
Injections per week7
Half-lifeNot reliably characterised in humans; free GHK is degraded quickly in plasma while the copper complex is more stable, and no published subcutaneous half-life exists.
TimingEvening dosing is common because injection-site stinging is easier to sleep through. Rotate sites; do not repeatedly inject the same spot.
Typical run length2-4 weeks, then at least an equal break
RoutesTopical, Subcutaneous
Molecular weight404 Da
SequenceGHK

GHK-Cu is about 16% copper by mass, so 2 mg delivers roughly 315 mcg of elemental copper straight past the gut's absorption control — this is why cycles are kept short rather than run continuously.

Reconstitution calculator

Pre-loaded with GHK-Cu’s vial size, water volume and typical dose. Change anything.

Typical: 2 mg · range 1–3

05101520253020 units0.3 mL insulin · U-100 · half-unit marks

Draw to

20 u

0.2 mL · 2 mg

Concentration

10 mg/mL

100 mcg per unit

Doses per vial

25

Vial lasts

3 weeks 4 days

Draw to 20 units on the barrel.

Once mixed
Refrigerate at 2-8 C in the dark and use within about 30 days; discard immediately if the blue colour fades or the solution goes cloudy.

Full calculator →
Suggested water5 mL per 50 mg vial
Common vial sizes50 mg, 100 mg

Add the bacteriostatic water down the vial wall and swirl gently; the solution should go a clear deep blue, and cloudiness or a green-brown tint means the copper complex has degraded and the vial should be discarded. 50 mg in 5 mL gives 10 mg/mL, so a 2 mg dose is 0.2 mL, or 20 units on a U-100 insulin syringe.

Storage

Before mixing

Sealed, dry and dark at 2-8 C for two years or more; light exposure degrades the copper complex faster than it does most peptides.

After mixing

Refrigerate at 2-8 C in the dark and use within about 30 days; discard immediately if the blue colour fades or the solution goes cloudy.

Reported benefits

  • Stimulates collagen, elastin and glycosaminoglycan synthesis in human skin studies
  • Improves wound closure and reduces scar formation in controlled topical trials
  • Modulates matrix metalloproteinases, clearing damaged matrix as well as laying down new
  • Antioxidant activity via copper delivery to superoxide dismutase
  • Topical use has a genuinely good safety record over decades of cosmetic sale
  • Reported improvements in hair follicle size and skin firmness with sustained topical use

Side effects

  • Marked injection-site stinging, redness and swelling — the most commonly reported problem by a wide margin
  • Blue-green staining or discoloration at the injection site
  • Nausea, metallic taste or headache, usually signs of dosing too high or too long
  • Copper accumulation with extended use, which can suppress zinc status and cause fatigue and anaemia
  • Topical use can cause irritation or contact dermatitis on sensitive skin

Do not use if

  • Wilson's disease or any other disorder of copper handling — absolute contraindication
  • Existing copper overload, or ongoing high-dose copper supplementation
  • Significant liver or kidney impairment, since both handle copper clearance
  • Pregnancy and breastfeeding — no data
  • Active cancer, given the compound's angiogenic and pro-proliferative activity

Evidence level — Early human

Small or early-phase human studies only.

Sold legally worldwide as a topical cosmetic ingredient; the injectable form is not approved as a drug anywhere and is supplied only as a research chemical.

Commonly run with

GHK-Cu FAQ

Should I inject it or just use it topically?+

For skin, hair and superficial scarring, topical is where all the human evidence sits and it avoids the copper-loading problem entirely. Injection is used by people chasing systemic connective-tissue and wound effects, but it has zero human trial support and carries a real heavy-metal dose.

Why does everyone insist on short cycles?+

Because you are injecting copper, not just a peptide. Roughly 16% of the mass is elemental copper delivered subcutaneously, bypassing the intestinal regulation that normally keeps copper status in range. Two to four weeks on with an equal break off is the standard community ceiling, and running it continuously is how people end up with copper-zinc imbalance.

Should I take zinc alongside it?+

Copper and zinc compete, and sustained copper loading can drive zinc down. If you are running injectable GHK-Cu for more than a couple of weeks, keeping a normal dietary zinc intake is sensible — but megadosing zinc to counteract it just swaps one imbalance for the other.

The solution turned pale or cloudy. Is it still usable?+

No. A healthy reconstituted GHK-Cu vial is a clear, deep blue. Colour loss or cloudiness means the copper complex has broken down, and at that point you have no idea what you are injecting. Discard it.

References

  1. 1.GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationBioMed Research International (2015) PMID 26236730
  2. 2.The human tri-peptide GHK and tissue remodelingJournal of Biomaterials Science, Polymer Edition (2008) PMID 18644225
  3. 3.The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive healthOxidative Medicine and Cellular Longevity (2012) PMID 22666519

More healing & recovery